The protein antagonizes the activity of neutrophil cathepsin G and mast cell chymase and has been implicated in neuroinflammation, neurodegeneration (Baker et al., 2007), and other types of brain conditions such as human prion diseases (Vanni et al., 2017). This evidence concerns the gene CMA1 and prion disease.